Asia · Regional markets · Mint
Small-cap stock under ₹50 jumps 7% despite weak trends on Dalal Street; here's why | Target price, stop-loss
Sudarshan Pharma shares rose 7% on Wednesday after the company migrated from BSE’s SME platform to the NSE main board. Its board is scheduled to review Q2 FY27 results and a…
Read the full article on Mint Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.livemint.com)


